Project Grant R21DE033170
Award Date
8/1/24
Completion Date
7/31/26
Dollars Obligated
$236K
Federal Agency
National Institute of Dental and Craniofacial Research
Federal Grant Program
93.121
Assistance Type
Project Grant
Place of Performance
New Jersey, USA
Similar Awards
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the CFDA Program 93.121 Oral Diseases and Disorders Research, provides $401,500.00 to Louisiana State University Health Sciences Center-Shreveport to investigate fundamental aspects of the innate immune response to SARS-CoV-2 within the salivary gland. The key objectives are to explore how antigen presentation mechanisms may shape or reflect local immune activity in this tissue, in order to...
This Project Grant award of $155,500 from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), will support a comprehensive examination of the oral virome and its interactions with the oral microbiome. The research aims to shed light on the role of viruses in maintaining oral health and contributing to disease, with the goal of illuminating a neglected aspect of the oral microenvironment and potentially...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $608,632.33 Project Grant under the Oral Diseases and Disorders Research program (CFDA 93.121) to The Research Foundation For The State University Of New York (RF SUNY). The award, effective September 1, 2024, supports a research project investigating the role of rare chemosensory epithelial cells known as "tuft cells" in salivary gland immunity. The project aims to utilize advanced microscopic techniques,...
The University of Illinois, under a $581,037 Project Grant award from the National Institutes of Health (NIH) Trans-NIH Research Support Program (CFDA 93.310), will conduct research to investigate the mechanisms underlying oral post-acute sequelae of COVID-19 (PASC) in minority populations. The key objectives are to: 1) analyze the impact of COVID-19 vaccination on oral PASC indicators and perturbations in oral immune surveillance in Black, Hispanic, and non-Hispanic White cohorts; and 2)...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), provides $241,500 in funding to The Research Foundation For The State University Of New York to conduct research aimed at identifying diffusible small molecules that regulate the replication of the oral pathogen Porphyromonas gingivalis. The research will utilize chemical and molecular genetic strategies to elucidate the...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research Federal Grant Program (CFDA 93.121), provides $808,264 to The Medical University of South Carolina to conduct research on the mechanisms of filopodia-mediated intracellular delivery of small interfering RNAs (siRNAs) via peptide carriers. The goal is to elucidate the mechanisms underlying filopodia-directed cell entry of the RD3AD-siRNA complex in...
This Project Grant award of $178,000.00 from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), will support research to characterize the biogenesis and biological significance of protein phosphoribosylation in the context of herpes simplex virus 1 (HSV-1) infection. The research aims to: 1) identify and characterize the enzyme(s) that catalyze the ADP-ribosylation of the HSV-1 structural protein VP22, and...
This federal Project Grant award of $339,000 was provided by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121). The funding supports research by New York University School of Medicine to investigate the role of autocrine cholinergic signaling in maintaining memory T cell responses in oral squamous cell carcinoma. The research project will be conducted from August 1, 2024 to July 31, 2026. As a leading...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), provides $111,701.00 to the University of Illinois at Chicago to conduct research on the mechanism and impact of Streptococcal RAS-RIPPS on the human oral microbiome. The award period runs from August 1, 2023 to July 31, 2025. The key objectives of this research project are to elucidate the mechanism of action of the RAS-RIPP...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a Project Grant (CFDA 93.121 - Oral Diseases and Disorders Research) in the amount of $473,632 to the University of Toledo on May 1, 2025. The purpose of this 3-year project is to investigate the role of megakaryocytes (MEGs) and their response to the cytokine interleukin-17 (IL-17) in oral mucosal immunity, particularly during oropharyngeal candidiasis caused by Candida albicans. The research aims to elucidate the...